Literature DB >> 31471665

Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict.

M S Rothman1, T P Olenginski2, I Stanciu3, K Krohn4, E M Lewiecki5.   

Abstract

Clinical practice guidelines provide helpful information for managing patients with metabolic bone disease. Good guidelines are based on the best available medical evidence; however, guidelines from different societies can conflict. Additionally, it is not possible for a guideline to anticipate the vast variability of circumstances, comorbidities, previous medical experiences, cultural differences, and preferences in real-world patients. Bone Health TeleECHO is a strategy for sharing knowledge on the care of patients with skeletal diseases through ongoing interactive videoconferences. We report three cases based on those presented at Bone Health TeleECHO, where, through discussion, treatment outside of commonly used guidelines was ultimately recommended. Guidelines developed by different organizations may provide "evidence-based" or "informed" recommendations which do not account for the variability of clinical circumstances encountered in the care of individual patients. This highlights the importance of Bone Health TeleECHO, where healthcare professionals can share knowledge, individualize treatment decisions, and improve patient care.Learning objectives At the end of this activity participants should be able to:• Distinguish between the onset and off of bisphosphonates versus other medications used in the prevention and treatment of osteoporosis and how this affects choice of a "drug holiday."• Understand the limitations of clinical practices guidelines in the care of an individual patient and how interactive video conferencing can assist with decision making.• Recognize that patients treated with glucocorticoids at high risk for fracture can benefit from more aggressive interventions for osteoporosis.

Entities:  

Keywords:  Guidelines; Osteoporosis treatment; Telehealth; Telemedicine

Mesh:

Substances:

Year:  2019        PMID: 31471665     DOI: 10.1007/s00198-019-05147-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

Review 2.  Project ECHO: Telehealth to Expand Capacity to Deliver Best Practice Medical Care.

Authors:  E Michael Lewiecki; Rachelle Rochelle
Journal:  Rheum Dis Clin North Am       Date:  2019-03-08       Impact factor: 2.670

3.  Telementoring: a novel approach to reducing the osteoporosis treatment gap.

Authors:  E M Lewiecki; J F Boyle; S Arora; M F Bouchonville; D H Chafey
Journal:  Osteoporos Int       Date:  2016-07-20       Impact factor: 4.507

4.  Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.

Authors:  Sundeep Khosla; Jane A Cauley; Juliet Compston; Douglas P Kiel; Clifford Rosen; Kenneth G Saag; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2016-12-29       Impact factor: 6.741

5.  Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 years.

Authors:  C Castelo-Branco; J Davila; M F Perelló; A Peguero; C Ros; M J Martínez-Serrano; J Balasch
Journal:  Climacteric       Date:  2014-01-25       Impact factor: 3.005

Review 6.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

7.  Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.

Authors:  John Yates; Elizabeth Barrett-Connor; Suna Barlas; Ya-Ting Chen; Paul D Miller; Ethel S Siris
Journal:  Obstet Gynecol       Date:  2004-03       Impact factor: 7.661

8.  Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.

Authors:  Cynthia A Stuenkel; Susan R Davis; Anne Gompel; Mary Ann Lumsden; M Hassan Murad; JoAnn V Pinkerton; Richard J Santen
Journal:  J Clin Endocrinol Metab       Date:  2015-10-07       Impact factor: 5.958

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

10.  Leveraging Scarce Resources With Bone Health TeleECHO to Improve the Care of Osteoporosis.

Authors:  E Michael Lewiecki; Rachelle Rochelle; Matthew F Bouchonville; David H Chafey; Thomas P Olenginski; Sanjeev Arora
Journal:  J Endocr Soc       Date:  2017-11-06
View more
  1 in total

Review 1.  Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends.

Authors:  K E Åkesson; K Ganda; C Deignan; M K Oates; A Volpert; K Brooks; D Lee; D R Dirschl; A J Singer
Journal:  Osteoporos Int       Date:  2022-03-24       Impact factor: 5.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.